Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Antiobesity Market In 2029?
The market size for antiobesity has significantly increased over the previous years. It is projected to escalate from $3.74 billion in 2024 to $4.1 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.7%. The past period’s growth can be ascribed to factors such as a heightened prevalence of obesity, enhanced awareness and education, modifications in lifestyle, and government policies.
Expectations are high for the antiobesity market, with significant expansion predicted in the coming years. The market is projected to reach $5.94 billion by 2029, experiencing a compound annual growth rate (CAGR) of 9.7%. This growth during the forecast period can be credited to market expansion and globalization. Anticipated trends for the forecast period encompass research and development, a focus on the patient, insurance coverage, technical innovations, telemedicine and digital health, new drug therapies, advancements in bariatric surgery, over-the-counter solutions, behavioural strategies, and applications for diet and weight control.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp
Which Primay Drivers Are Accelerating Growth in the Antiobesity Market?
The significant rise in obesity is a pressing health issue worldwide. Each year, the incidence of obesity continues to grow on a global scale. The World Obesity Atlas, a UK organisation focusing on obesity, estimated in May 2022 that by 2030, over 1 billion individuals globally could be affected by obesity. Factors such as the heightened intake of unhealthy and processed food, inadequate physical exercise, and insufficient understanding of obesity-related risks contribute to this. Consequently, the growing need for anti-obesity medications would progressively fuel market growth in the future.
Which Primary Segments of the Antiobesity Market Are Driving Growth and Industry Transformations?
The antiobesity market covered in this report is segmented –
1) By Drug Class: Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs
2) By Type: Prescription Drugs (Rx), OTC Drugs
3) By Medication: Monotherapies, Polytherapies
Subsegments:
1) By Peripherally Acting Anti-Obesity Drugs: Orlistat, Lorcaserin
2) By Centrally Acting Anti-Obesity Drugs: Phentermine, Topiramate, Naltrexone-Bupropion Combination, Liraglutide
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3403&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Antiobesity Market?# Market?
North America was the largest region in the anti-obesity market in 2024. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Technological Trends Are Reshaping the Antiobesity Industry Dynamics?
Leading enterprises in the anti-obesity drug market are prioritizing the creation of innovative products such as Mounjaro (tirzepatide) to deliver dependable solutions to their clients. This drug is utilized as an anti-obesity treatment for adults who are battling obesity or overweight challenges accompanied by weight-related health complications. Eli Lilly and Company, a pharmaceutical corporation based in the US, for example, introduced Mounjaro (tirzepatide) in October 2022. Endorsed as a fast-track designation treatment by the Food and Drug Administration (FDA), a federal agency in the US, this drug is injectable and serves as an effective strategy for those dealing with obesity to meet their weight loss targets. It is administered to adults with type 2 diabetes and is recommended alongside a proper diet and exercise regime for better blood sugar (glucose) management.
View the full report here:
https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report
What Parameters Are Used to Define the Antiobesity Market?
The anti-obesity drugs refer to the medications that are used to lower or regulate weight of a patient. These drugs interfere with one of the body’s basic functions, controlling weight, by affecting either appetite or calorie absorption. Dieting (a healthy diet and caloric restriction) and exercise continue to be the main therapeutic approaches for overweight and obese people.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3403
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model